|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Izumi D, Zhu Z, Chen Y, Toden S, Huo X,
Kanda M, Ishimoto T, Gu D, Tan M, Kodera Y, et al: Assessment of
the diagnostic efficiency of a liquid biopsy assay for early
detection of gastric cancer. JAMA Netw Open. 4:e21211292021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shoda K, Ichikawa D, Fujita Y, Masuda K,
Hiramoto H, Hamada J, Arita T, Konishi H, Kosuga T, Komatsu S, et
al: Clinical utility of circulating cell-free Epstein-Barr virus
DNA in patients with gastric cancer. Oncotarget. 8:28796–28804.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shoda K, Ichikawa D, Fujita Y, Masuda K,
Hiramoto H, Hamada J, Arita T, Konishi H, Komatsu S, Shiozaki A, et
al: Monitoring the HER2 copy number status in circulating tumor DNA
by droplet digital PCR in patients with gastric cancer. Gastric
Cancer. 20:126–135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miki Y, Yashiro M, Moyano-Galceran L,
Sugimoto A, Ohira M and Lehti K: Crosstalk between cancer
associated fibroblasts and cancer cells in scirrhous type gastric
cancer. Front Oncol. 10:5685572020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang KH, Chen MH, Fang WL, Lin CH, Chao
Y, Lo SS, Li AF, Wu CW and Shyr YM: The clinicopathological
characteristics and genetic alterations of signet-ring cell
carcinoma in gastric cancer. Cancers (Basel). 12:23182020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi H, Qi C, Meng L, Yao H, Jiang C, Fan
M, Zhang Q, Hou X and Lin R: Bone marrow-derived mesenchymal stem
cells promote Helicobacter pylori-associated gastric cancer
progression by secreting thrombospondin-2. Cell Prolif.
54:e131142021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeong HY, Ham IH, Lee SH, Ryu D, Son SY,
Han SU, Kim TM and Hur H: Spatially distinct reprogramming of the
tumor microenvironment based on tumor invasion in diffuse-type
gastric cancers. Clin Cancer Res. 27:6529–6542. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Venning FA, Zornhagen KW, Wullkopf L,
Sjölund J, Rodriguez-Cupello C, Kjellman P, Morsing M, Hajkarim MC,
Won KJ, Erler JT and Madsen CD: Deciphering the temporal
heterogeneity of cancer-associated fibroblast subpopulations in
breast cancer. J Exp Clin Cancer. 40:1752021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nurmik M, Ullmann P, Rodriguez F, Haan S
and Letellier E: In search of definitions: Cancer-associated
fibroblasts and their markers. Int J Cancer. 146:895–905. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maruyama S, Furuya S, Shiraishi K, Shimizu
H, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M,
et al: Podoplanin expression as a prognostic factor in gastric
cancer. Anticancer Res. 38:2717–2722. 2018.PubMed/NCBI
|
|
12
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. 8th ed. John
Wiley & Sons, Ltd.; 2017
|
|
13
|
Tomita H, Ichikawa D, Ikoma D, Sai S, Tani
N, Ikoma H, Fujiwara H, Kikuchi S, Okamoto K, Ochiai T and Otsuji
E: Quantification of circulating plasma DNA fragments as tumor
markers in patients with esophageal cancer. Anticancer Res.
27:2737–2741. 2007.PubMed/NCBI
|
|
14
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Zhou Q, Wang H, Zhuo W, Ding Y, Lu
J, Wu G, Xu N and Teng L: Predicting peritoneal dissemination of
gastric cancer in the Era of precision medicine: Molecular
characterization and biomarkers. Cancers (Basel). 12:22362020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kasashima H, Yashiro M, Nakamae H,
Kitayama K, Masuda G, Kinoshita H, Fukuoka T, Hasegawa T, Nakane T,
Hino M, et al: CXCL1-Chemokine (C-X-C Motif) receptor 2 signaling
stimulates the recruitment of bone marrow-derived mesenchymal cells
into diffuse-type gastric cancer stroma. Am J Pathol.
186:3028–3039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Cao Y, Lv K, Gu Y, Jin K, He X,
Fang H, Fei Y, Shi M, Lin C, et al: Tumor-infiltrating
podoplanin+ cells in gastric cancer: Clinical outcomes
and association with immune contexture. Oncoimmunology.
9:18450382020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cimini M and Kishore R: Role of
podoplanin-positive cells in cardiac fibrosis and angiogenesis
after ischemia. Front Physiol. 12:6672782021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suzuki-Inoue K: Platelets and
cancer-associated thrombosis: Focusing on the platelet activation
receptor CLEC-2 and podoplanin. Blood. 134:1912–1918. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quintanilla M, Montero-Montero L, Renart J
and Martín-Villar E: Podoplanin in Inflammation and Cancer. Int J
Mol Sci. 20:7072019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sugai T, Uesugi N, Kitada Y, Yamada N,
Osakabe M, Eizuka M, Sugimoto R, Fujita Y, Kawasaki K, Yamamoto E,
et al: Analysis of the expression of cancer-associated fibroblast-
and EMT-related proteins in submucosal invasive colorectal cancer.
J Cancer. 9:2702–2712. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neri S, Ishii G, Hashimoto H, Kuwata T,
Nagai K, Date H and Ochiai A: Podoplanin-expressing
cancer-associated fibroblasts lead and enhance the local invasion
of cancer cells in lung adenocarcinoma. Int J Cancer. 137:784–796.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao X, Pan Y, Ren W, Shen F, Xu M, Yu M,
Fu J, Xia L, Ruan C and Zhao Y: Plasma soluble podoplanin is a
novel marker for the diagnosis of tumor occurrence and metastasis.
Cancer Sci. 109:403–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kemi N, Eskuri M, Herva A, Leppänen J,
Huhta H, Helminen O, Saarnio J, Karttunen TJ and Kauppila JH:
Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J
Cancer. 119:435–439. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki-Inoue K, Inoue O, Ding G, Nishimura
S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K,
et al: Essential in vivo roles of the C-type lectin receptor
CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by
blood/lymphatic misconnections and impaired thrombus formation of
CLEC-2-deficient platelets. J Biol Chem. 285:24494–24507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki-Inoue K: Roles of the
CLEC-2-podoplanin interaction in tumor progression. Platelets. 1–7.
2018.(Epub ahead of print). PubMed/NCBI
|
|
27
|
Carrasco-Ramírez P, Greening DW, Andrés G,
Gopal SK, Martín-Villar E, Renart J, Simpson RJ and Quintanilla M:
Podoplanin is a component of extracellular vesicles that reprograms
cell-derived exosomal proteins and modulates lymphatic vessel
formation. Oncotarget. 7:16070–16089. 2016. View Article : Google Scholar : PubMed/NCBI
|
